{"disease":{"id":"arsenic-trioxide","name":"arsenic trioxide"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05682131","title":"South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":210,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT04695223","title":"Arsenic Trioxide for Structural p53 Mutations","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Shanghai Changzheng Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}